Aditi Singh, M., Arthi Sridhar, M., Aastha Poddar, M., Anastasios Dimou, M., Kaushal Parikh, M., Mohamed Shanshal, M., . . . Konstantinos Leventakos, M. Combination of Lurbinectedin and Osimertinib for Treatment of EGFR-Mutated Transformed SCLC: A Brief Report. Elsevier.
Chicago Style (17th ed.) CitationAditi Singh, MBBS, et al. Combination of Lurbinectedin and Osimertinib for Treatment of EGFR-Mutated Transformed SCLC: A Brief Report. Elsevier.
MLA (9th ed.) CitationAditi Singh, MBBS, et al. Combination of Lurbinectedin and Osimertinib for Treatment of EGFR-Mutated Transformed SCLC: A Brief Report. Elsevier.
Warning: These citations may not always be 100% accurate.